头颈部鳞状细胞癌
癌症研究
细胞外基质
肿瘤微环境
头颈部癌
医学
癌症
肿瘤科
内科学
肿瘤细胞
生物
细胞生物学
作者
Muzafar A. Macha,Nissar Ahmad Wani,Rais A. Ganai,Ajaz A. Bhat,Abid Hamid,Sheema Hashem,Mohammad Haris,Sham S. Chauhan,Mohammad Afzal Zargar,Surinder K. Batra
标识
DOI:10.1007/978-3-030-59038-3_2
摘要
Head and neck squamous cell carcinomas (HNSCCs) are a group of heterogeneous aggressive tumors affecting more than half a million patients worldwide annually. While the tobacco- and alcohol-associated HNSCC tumors are declining, human papillomavirus (HPV)-induced tumors are on rise. Despite recent advances in multimodality therapeutic interventions including surgery in combination with chemoradiation therapy (CRT), the overall 5-year survival has not improved more than 50%. The underlying reasons for this dismal prognosis is the intrinsic or acquired resistance to CRT. While previous studies were focused to target tumor cells, recent findings have implicated the involvement of tumor microenvironment (TME) on tumor progression and response to therapy. HNSCC TME includes cancer-associated fibroblasts (CAFs), endothelial cells, immune cells, endocrine cells, and the extracellular matrix (ECM) proteins including collagen and fibronectin. Understanding the crosstalk between TME and cancer cells is important to formulate more effective novel therapies and to overcome resistance mechanisms. Here, we summarized the current literature on recent advances on HNSCC TME with special emphasis on novel cell–cell interactions and therapies currently under development.
科研通智能强力驱动
Strongly Powered by AbleSci AI